Use of a Novel SUBCUTaneous Preparation of Furosemide to Facilitate Early Supported Discharge of Patients With Heart Failure
NCT05419115
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
172
Enrollment
OTHER
Sponsor class
Conditions
Heart Failure
Interventions
DRUG:
SQIN-Furosemide
DEVICE:
SQIN-Infusor
Sponsor
NHS Greater Glasgow and Clyde
Collaborators
[object Object]